InMed Pharmaceuticals: The Clinical-Stage Company Setting Sites On Dominating Rare Cannabinoid Production And Commercialization Across Global Markets

Shane Johnson, SVP and General Manager of Baymedica of InMed Pharmaceuticals INM, was a guest speaker at Benzinga’s All Access on June 17th, 2022. 

InMed Pharmaceuticals is an emerging global leader in the development, manufacturing and commercialization of rare cannabinoids and health and wellness consumer products. 

Watch the full interview here

Feature photo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechCannabisPenny StocksHealth CareMarketsGeneralBenzinga All AccessInMed Pharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.